CEO Lars Fruergaard Jorgensen discusses Wegovy
They have been a few rocky months to Novo Nordisk. IQVIA prescription data suggest that the Novo Wegovy Obesity Medication…
health care industry
Teladoc Health to acquire Catapult Health in a $ 65 million agreement
Pavlo Gonchanche | LIGHTROCKET | Getty images Teradoc health The shares rose 6% on Wednesday after the company announced that…
Trump sued for the surveys of January 6, the elimination of clinical data of the FDA
The Trump administration was sued on Tuesday in two separated civil complaints related to a request for information on FBI…
Merck profits (MRK) Q4 2024
Soup images | LIGHTROCKET | Getty images Merck On Tuesday, he issued an income guide of 2025 per full year…
Trump's tariffs could increase drug costs, worsen scarcity
Shana Novak | Stone | Getty images President Donald Trump's pronounced tariffs on Canada, Mexico and China could worsen the…
Reid Hoffman launches Manas AI, a new drug discovery startup
Reid Hoffman, Greylock partner and LinkedIn co -founder, speaks during the WSJ Tech Live conference organized by the Wall Street…
We are lightening in a stock of rally that has become too big in our portfolio
The sale also occurs when our trusted impulse indicator moved more to the overcompra territory.
Novo Nordisk Ozempic wins FDA approval for chronic kidney disease
Food and medication administration approved Tuesday Novo Nordisk'S Ozempic to treat chronic kidney disease in patients who also have type…
Trump made broad changes in medical care in the first week
The president of the United States, Donald Trump, attends a meeting of the Republican Member Conference of the Chamber at…
We are reducing our target price in Danaher as frustration is mounted after a messy quarter
Danaher's actions are under pressure on Wednesday, since the profit results of the fourth quarter of the Holding Club reached…